NCT02862275 2026-04-21
Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer
National Cancer Institute (NCI)
Phase 1 Active not recruiting
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)